Abstract:Graphical abstract Highlights • Antiphospholipid syndrome is a rare systemic autoimmune disease characterized by recurrent pregnancy morbidity or thrombosis in combination with the persistent presence of antiphospholipid antibodies in plasma/serum • Specialists in laboratory medicine should take responsibility for the entire analytical process, so that possible interferences are minimized, and physicians obtain reliable results of the patient's laboratory findings in a timely manner • Due to possible problems in performing tests on aPLs for a more reliable (optimal) interpretation of laboratory findings, a close cooperation between laboratory specialists and clinical specialists is needed Antiphospholipid syndrome (APS) is a rare systemic autoimmune disease characterized by recurrent pregnancy morbidity or thrombosis in combination with the persistent presence of antiphospholipid antibodies (aPLs) in plasma/serum. Antiphospholipid antibodies are a heterogeneous, overlapping group of autoantibodies, of which anti-β2-glycoprotein I (aβ2GPI), anticardiolipin (aCL) antibodies and antibodies that prolong plasma clotting time in tests in vitro known as lupus anticoagulant (LAC) are included in the laboratory criteria for the diagnosis of APS. The presence of LAC antibodies in plasma is indirectly determined by measuring the length of coagulation in two tests - activated partial thromboplastin time (aPTT) and diluted Russell's viper venom time (dRVVT). The concentration of aβ2GPI and aCL (immunglobulin G (IgG) and immunoglobulin M (IgM) isotypes) in serum is directly determined by solid-phase immunoassays, either by enzyme-linked immunosorbent assay (ELISA), fluoroimmunoassay (FIA), immunochemiluminescence (CLIA) or multiplex flow immunoassay (MFIA). For patient safety, it is extremely important to control all three phases of laboratory testing, i.e. preanalytical, analytical and postanalytical phase. Specialists in laboratory medicine must be aware of interferences in all three phases of laboratory testing, in order to minimize these interferences. The aim of this review was to show the current pathophysiological aspects of APS, the importance of determining aPLs-a in plasma/serum, with an emphasis on possible interferences that should be taken into account when interpreting laboratory findings.

Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome

[Antiphospholipid antibodies: clinical significance and biological diagnosis]

Noncriteria antiphospholipid antibodies in antiphospholipid syndrome

Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic.

Antiphospholipid antibody testing

Antiphospholipid antibodies in patients with antiphospholipid syndrome

Non-criteria Antiphospholipid Antibodies in Antiphospholipid Syndrome: Diagnostic Value Added

Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies

Unclassified antiphospholipid antibodies may improve the accuracy of the diagnosis of antiphospholipid antibody syndrome

Prevalence of Aphosphatidylserine/prothrombin Antibodies and Association with Antiphospholipid Antibody Profiles in Patients with Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis.

Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays

Antiphospholipid antibodies and antiphospholipid syndrome

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management

Interaction of antiphospholipid antibodies with endothelial cells in antiphospholipid syndrome

Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?

16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome

Clinical and Laboratory Diagnosis of Antiphospholipid Syndrome: A Review

Deciphering the clinical significance of longitudinal antiphospholipid antibody titers

The Issue of the Antiphospholipid Antibody Syndrome